150 related articles for article (PubMed ID: 12540841)
1. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway.
Wu WS; Xu ZX; Hittelman WN; Salomoni P; Pandolfi PP; Chang KS
J Biol Chem; 2003 Apr; 278(14):12294-304. PubMed ID: 12540841
[TBL] [Abstract][Full Text] [Related]
2. The promyelocytic leukemia protein represses A20-mediated transcription.
Wu WS; Xu ZX; Chang KS
J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
[TBL] [Abstract][Full Text] [Related]
3. Promyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.
Kuwayama K; Matsuzaki K; Mizobuchi Y; Mure H; Kitazato KT; Kageji T; Nakao M; Nagahiro S
Neuro Oncol; 2009 Apr; 11(2):132-41. PubMed ID: 18812519
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB-regulated expression of cellular FLIP protects rheumatoid arthritis synovial fibroblasts from tumor necrosis factor alpha-mediated apoptosis.
Bai S; Liu H; Chen KH; Eksarko P; Perlman H; Moore TL; Pope RM
Arthritis Rheum; 2004 Dec; 50(12):3844-55. PubMed ID: 15593196
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways.
Suk K; Chang I; Kim YH; Kim S; Kim JY; Kim H; Lee MS
J Biol Chem; 2001 Apr; 276(16):13153-9. PubMed ID: 11278357
[TBL] [Abstract][Full Text] [Related]
7. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
Testa U; Grignani F; Samoggia P; Zanetti C; Riccioni R; Lo Coco F; Diverio D; Felli N; Passerini CG; Grell M; Pelicci PG; Peschle C
J Clin Invest; 1998 May; 101(10):2278-89. PubMed ID: 9593784
[TBL] [Abstract][Full Text] [Related]
8. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
Giannì M; de Thé H
Leukemia; 1999 May; 13(5):739-49. PubMed ID: 10374879
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
Moon DO; Kim MO; Lee JD; Choi YH; Kim GY
Cancer Lett; 2010 Feb; 288(2):183-91. PubMed ID: 19619938
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
Imose M; Nagaki M; Naiki T; Osawa Y; Brenner DA; Asano T; Hayashi H; Kato T; Moriwaki H
Liver Int; 2003 Oct; 23(5):386-96. PubMed ID: 14708901
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-mediated apoptosis requires NF-kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells.
Kim YS; Schwabe RF; Qian T; Lemasters JJ; Brenner DA
Hepatology; 2002 Dec; 36(6):1498-508. PubMed ID: 12447876
[TBL] [Abstract][Full Text] [Related]
12. The promyelocytic leukemia protein PML regulates c-Jun function in response to DNA damage.
Salomoni P; Bernardi R; Bergmann S; Changou A; Tuttle S; Pandolfi PP
Blood; 2005 May; 105(9):3686-90. PubMed ID: 15626733
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Ref-1 inhibits hypoxia and tumor necrosis factor-induced endothelial cell apoptosis through nuclear factor-kappab-independent and -dependent pathways.
Hall JL; Wang X; Van Adamson ; Zhao Y; Gibbons GH
Circ Res; 2001 Jun; 88(12):1247-53. PubMed ID: 11420300
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
15. Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein.
Xiao CW; Yan X; Li Y; Reddy SA; Tsang BK
Endocrinology; 2003 Feb; 144(2):623-30. PubMed ID: 12538625
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway.
Li L; He D; He H; Wang X; Zhang L; Luo Y; Nan X
Cancer Lett; 2006 May; 236(2):259-68. PubMed ID: 16216409
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic leukemia protein 4 induces apoptosis by inhibition of survivin expression.
Xu ZX; Zhao RX; Ding T; Tran TT; Zhang W; Pandolfi PP; Chang KS
J Biol Chem; 2004 Jan; 279(3):1838-44. PubMed ID: 14597622
[TBL] [Abstract][Full Text] [Related]
18. PML is essential for multiple apoptotic pathways.
Wang ZG; Ruggero D; Ronchetti S; Zhong S; Gaboli M; Rivi R; Pandolfi PP
Nat Genet; 1998 Nov; 20(3):266-72. PubMed ID: 9806545
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
Wu WS; Xu ZX; Ran R; Meng F; Chang KS
Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]